Cas:24048-13-3 2,6,10-trimethylundeca-5,9-dienal manufacturer & supplier

Chemical Name:2,6,10-trimethylundeca-5,9-dienal

CAS.NO:24048-13-3

Synonyms:2,6,10-Trimethyl-5,9-undecadien-1-al;EINECS 258-966-6;5,9-Undecadienal,2,6,10-trimethyl;EINECS 245-999-6

Molecular Formula:C₁₄H₂₄O

Molecular Weight:208.34000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:292.8ºC at 760 mmHg

Density:0.853 g/cm3

Index of Refraction:

PSA:17.07000

Exact Mass:208.18300

LogP:4.29430

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,6,10-Trimethyl-5,9-undecadien-1-al chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 245-999-6 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5,9-Undecadienal,2,6,10-trimethyl Use and application,2,6,10-Trimethyl-5,9-undecadien-1-al technical grade,usp/ep/jp grade.

Related News: Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes. 2,6,10-trimethylundeca-5,9-dienal manufacturer It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad. 2,6,10-trimethylundeca-5,9-dienal supplier That’s four days earlier than it had initially planned. Delta’s last China-bound flight left on Saturday, February 1, and its final returning flight from China to the United States leaves on Sunday. 2,6,10-trimethylundeca-5,9-dienal vendor Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes. 2,6,10-trimethylundeca-5,9-dienal factory Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.